Icon

COMBIGAN (nda021398)- (0.2%;EQ 0.5% BASE)

BRIMONIDINE TARTRATE; TIMOLOL MALEATE ABBVIE
0.2%;EQ 0.5% BASE
Yes Yes
2023-Jan-19 Expired
None None
None No
COMBIGAN® is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP; the IOP-lowering of COMBIGAN® dosed twice a day was slightly less than that seen with the concomitant administration of timolol maleate ophthalmic solution, 0.5% dosed twice a day and brimonidine tartrate ophthalmic solution, 0.2% dosed three times per day.
7 1 6
Total Other Developers 23
Drugs with Suitability No
0.2%;EQ 0.5% BASE ** ** Up - 5
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ******* ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****,, ***, *** ******, ***** (***) ***
****** ******* ********** ** *********** ************** *, **********, ****, *********** (***) ***
****** ******* ******* *************** ******* *********** ****** **. **,** *** **, *******, ****** *****, **********, ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ******** ***, **** **. ****/****, ******* - *********, ****** - *****, ********, ******* ******, ***** (***) ***
****** ******** ****** *** *********** ***** **, *** *********** ** ************-****; ********-***, ********, ******** *****, *****, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.